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Abstract To analyze the coupling of GK subunits to the rat
neurotensin receptor NTS-1 (NTR), fusion proteins were
expressed in Escherichia coli with various GK subunits covalently
linked to the receptor C-terminus. The presence of GKq or GKi=q,
in which the six C-terminal residues of GKi1 were replaced with
those from GKq, increased the percentage of receptors in the
agonist high-affinity state. This effect was less pronounced for
wild-type GKi1 and not observed for GKi=s. Functional coupling
of neurotensin receptor to GK was demonstrated by neurotensin-
induced [35S]GTPQS binding for the GKq, GKi=q and GKi1
subunits, but not for GKi=s. Our results extend previous findings
of the dual coupling of NTR to pertussis toxin-sensitive and
-insensitive G-proteins in Chinese hamster ovary cells with
preference for the latter. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
The rat high-a⁄nity neurotensin receptor NTS-1 (NTR) [1]
is an integral membrane protein and belongs to the large
family of seven-helix G-protein-coupled receptors (GPCRs)
(see [2]). Its natural ligand is neurotensin (NT), a 13 amino
acid peptide [3], which is involved in intercellular communi-
cation within the central nervous system and peripheral or-
gans. NTR and its N-terminally truncated form (T43NTR)
have been expressed as maltose binding protein (MBP) fusions
in Escherichia coli [4,5] and have been puri¢ed in the presence
of detergent in functional form [5^7].
Binding studies using membrane-bound NTR expressed in
mammalian cells or in insect cells have revealed high-a⁄nity
agonist binding sites which are converted into low-a⁄nity
binding sites in the presence of non-hydrolyzable GTP ana-
logues [8^10]; this probably indicates the coupling of NTR to
endogenous G-proteins. Furthermore, pertussis toxin (PTX)-
sensitive and PTX-insensitive G-proteins, linked to the cAMP
and inositol phosphate messenger systems, respectively, have
been implicated in coupling [11^17]. However, the interpreta-
tion of such studies and the identi¢cation of the respective G-
proteins coupled to NTR have often been complicated by the
presence of multiple endogenous heterotrimeric G-proteins
and di¡erences in the cell lines used for investigation.
We have analyzed the coupling of GK protein subunits to
the bacterially expressed rat NTR using a GPCR^GK fusion
protein approach combined with [3H]NT and GTPQS (guano-
sine 5P-O-(3-thiotriphosphate)) binding experiments. Func-
tional expression of GPCRs in E. coli provides the opportu-
nity to study receptor properties in a background free of
heterotrimeric G-proteins and/or pharmacologically similar
receptor subtypes [18^20]. We provide evidence for receptor
interaction with both GKq- and GKi-type proteins covalently
linked to the receptor C-terminus. Our results support pre-
vious data [21] of the dual coupling of NTR to PTX-sensitive
and -insensitive G-proteins with predominant coupling to
PTX-insensitive G-proteins.
2. Materials and methods
2.1. Expression of NTR fusion proteins in E. coli and membrane
preparation
The fusion protein MBP-T43NTR-TrxA-H10 consists of the E. coli
MBP (Lys-1 to Thr-366), followed by glycine, serine, the N-terminally
truncated NTR (T43NTR, Thr-43 to Tyr-424) [5], three alanine res-
idues, the E. coli thioredoxin (TrxA, Ser-2 to Ala-109), glycine, threo-
nine and a deca-histidine tail (H10) [6]. In MBP-T43NTR-Gq and
MBP-T43NTR-Gi, Tyr-424 of NTR is followed by three alanine res-
idues and the mouse GKq protein (Thr-2 to Val-359) [22] or the rat
GKi1 subunit (Gly-2 to Phe-354) [23], respectively. MBP-T43NTR-Gi/
q and MBP-T43NTR-Gi/s contain chimeric GKi1 subunits in which
the six C-terminal amino acid residues were replaced with the equiv-
alent sequences of the mouse GKq protein (Lys-Glu-Tyr-Asn-Leu-Val)
or the rat GKs subunit (Arg-Gln-Tyr-Glu-Leu-Leu) [23], respectively.
Expression of membrane-inserted receptors in E. coli DH5K was per-
formed at 20‡C using the expression vector pRG/III-hs-MBP [5]. The
preparation of crude membranes has been described previously [5].
0014-5793 / 01 / $20.00 ß 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 2 2 8 1 - 5
*Corresponding author. Fax: (44)-1223-213556.
E-mail: rkg@mrc-lmb.cam.ac.uk
1 Also corresponding author. Fax: (32)-2-764 5460;
E-mail: emmanuel.hermans@farl.ucl.ac.be
Abbreviations: CHO, Chinese hamster ovary; Gi/q, GKi1 subunit in
which the six C-terminal amino acid residues were replaced with the
six C-terminal residues of GKq ; Gi/s, GKi1 subunit containing the six
C-terminal amino acid residues of GKs ; GPCR, seven-helix G-pro-
tein-coupled receptor; GTPQS, guanosine 5P-O-(3-thiotriphosphate);
MBP, Escherichia coli maltose binding protein; NT, neurotensin;
NTR, high-a⁄nity neurotensin receptor NTS-1; PTX, pertussis toxin;
TrxA, Escherichia coli thioredoxin
FEBS 24717 26-3-01
FEBS 24717 FEBS Letters 493 (2001) 101^105
Protein contents were determined by the method of Scha¡ner and
Weissmann [24] using bovine serum albumin as the standard.
2.2. Expression of NTR in Chinese hamster ovary (CHO) cells
The characterization of CHO cells expressing the rat NTR in func-
tional form (CHO-NTR) has previously been reported [25,26]. Bind-
ing experiments were performed on crude homogenates prepared as
described [26].
2.3. Ligand binding analyses
Crude E. coli membranes (100 Wl) were washed twice with 500 Wl of
ice-cold TE bu¡er (50 mM Tris^HCl pH 7.4, 1 mM EDTA) using a
bench top microcentrifuge at 10 500Ug for 3 min at 4‡C. Saturation
binding analyses at equilibrium with the agonist [3H]NT (New Eng-
land Nuclear) on ¢ve di¡erent membrane preparations (MBP-
T43NTR-TrxA-H10: 0.4^1.2 Wg of membrane protein per assay
tube, MBP-T43NTR-Gq: 0.3^0.6 Wg, MBP-T43NTR-Gi: 0.2^0.3 Wg,
MBP-T43NTR-Gi/q: 0.2^0.4 Wg, MBP-T43NTR-Gi/s: 0.2^0.3 Wg)
were performed in TEBB bu¡er (50 mM Tris^HCl pH 7.4, 1 mM
EDTA, 40 Wg of bacitracin per ml, 0.1% (w/v) bovine serum albumin)
[27] in a ¢nal volume of 100 Wl. When indicated, MgCl2 was added to
the assay bu¡er at a ¢nal concentration of 5 mM. Non-speci¢c bind-
ing was determined in the presence of 2 WM unlabeled NT (Sigma).
Samples were incubated for 30 min at room temperature. The assay
was terminated by centrifugation (10 500Ug, 4 min) at room temper-
ature. The membrane pellet was resuspended in 70 Wl of 0.1 M formic
acid after removal of the supernatant containing unbound [3H]NT.
Bound ligand was analyzed by liquid scintillation counting. All experi-
ments were performed in duplicate.
Data from saturation assays were analyzed by non-linear least-
squares curve-¢tting using the program Ebda/Ligand [28,29]. Im-
provement of an individual ¢t assuming two states was considered
signi¢cant if P values of less than 0.05 were obtained in an F test.
BH values (percentage of receptors in the high-a⁄nity state) and dis-
sociation constants were compared by means of an unpaired t-test
(two-tail) or one-way analysis of variance (Anova) (GraphPad Prism
software). The threshold P value was set to 0.05.
2.4. Binding of [35S]GTPQS
The binding experiments were performed at 30‡C in a ¢nal volume
of 1 ml in polypropylene tubes containing 20 Wg (CHO-NTR homo-
genates) or 100 Wg (E. coli membranes) of protein. The binding bu¡er
consisted of 50 mM Tris^HCl pH 7.4, 1 mM EDTA, 5 mM MgCl2,
100 mM NaCl, 1 WM 1,10-phenanthroline, 0.1% bovine serum albu-
min, 1 WM GDP and 1 mM dithiothreitol. Binding reactions were
initiated by the addition of [35S]GTPQS (Amersham, speci¢c activity
1000 Ci/mmol) at a ¢nal concentration of 0.1 nM. Non-speci¢c bind-
ing was determined in the presence of 0.1 mM guanylylimidodiphos-
phate. After incubation for 30 min, the reactions were terminated by
dilution with 3 ml of ice-cold washing bu¡er (50 mM Tris^HCl pH
7.4, 1 mM EDTA, 5 mM MgCl2, 100 mM NaCl) and immediate
¢ltration over GF/B glass ¢ber ¢lters (Whatman) followed by two
washes with washing bu¡er, using a 24-channel harvester (Semat,
UK). The amount of [35S]GTPQS trapped on the ¢lter was determined
by liquid scintillation counting. All binding data were analyzed by
non-linear regression using the software GraphPad Prism.
3. Results
3.1. Expression of MBP-T43NTR fusion proteins in E. coli
The fusion proteins MBP-T43NTR-TrxA-H10, MBP-
T43NTR-Gq, MBP-T43NTR-Gi, MBP-T43NTR-Gi/q and
MBP-T43NTR-Gi/s (Fig. 1) were produced in membrane-in-
serted form in E. coli. Their presence was detected with anti-
MBP antisera (New England Biolabs) as described [4] (data
not shown). Their agonist binding properties are shown in
Table 1.
3.2. MBP-T43NTR-GK fusion proteins expressed in E. coli
bind agonist with high and low a⁄nity
[3H]NT binding assays performed with the fusion proteins
MBP-T43NTR-Gq, -Gi, -Gi/q and -Gi/s showed the presence
of two independent populations of binding sites with high and
low a⁄nity for NT (Table 1, Fig. 2). This was also found for
MBP-T43NTR-TrxA-H10 which lacks a C-terminal GK moi-
ety (R. Grisshammer, unpublished work). However, the per-
centage of receptors in the high-a⁄nity state was signi¢cantly
higher for the GKq (BH = 46.9%) and GKi=q (BH = 49.0%) pro-
teins compared to that of MBP-T43NTR-TrxA-H10
(BH = 22.9%) (t-test : P = 0.005 and P = 0.002), indicating a
possible stabilization of the receptor high-a⁄nity state by
the GKq and GKi=q moieties. In contrast, the percentage of
MBP-T43NTR-Gi/s in the high-a⁄nity state (BH = 28.2%)
was not di¡erent from that observed for MBP-T43NTR-
TrxA-H10 (t-test : P = 0.53). For MBP-T43NTR-Gi, an inter-
mediate BH value of 34.6% was obtained. The di¡erence be-
tween this value and that obtained for MBP-T43NTR-TrxA-
H10 is not signi¢cant (t-test : P = 0.08), but is borderline sig-
ni¢cant when compared with the data obtained for MBP-
T43NTR-Gq and MBP-T43NTR-Gi/q (Anova: P = 0.047).
3.3. Agonist-induced [35S]GTPQS binding to
MBP-T43NTR-GK fusion proteins expressed in E. coli
As previously described for the CHO-NTR system, agonist-
induced exchange of GDP for [35S]GTPQS in the nucleotide
binding pocket of GK proteins requires the presence of NaCl
[26]. The lower potency of NT found in these experiments is a
consequence of the decreased a⁄nity of NT for its receptor in
the presence of sodium ions.
NTR has been reported to couple to both PTX-sensitive
and PTX-insensitive G-proteins [21]. This prompted us to in-
vestigate NT-induced [35S]GTPQS binding to fusion proteins
with either GKi1 or GKq covalently linked to the receptor C-
Table 1
Saturation binding analyses with [3H]NT of MBP-T43NTR fusion proteins using washed membrane preparations from E. coli
Fusion protein Additions to TEBB assay bu¡er pKDH pKDL Bmax (pmol/
mg)
BH (%)
MBP-T43NTR-TrxA-H10 (n = 6) none 9.80 þ 0.09 8.67 þ 0.11 23.7 þ 2.3 22.9 þ 4.4
MBP-T43NTR-Gq (n = 5) none 10.15 þ 0.08* 8.86 þ 0.11 12.4 þ 0.5 39.6 þ 3.4
MBP-T43NTR-Gq (n = 5) 5 mM MgCl2 10.05 þ 0.06 8.97 þ 0.11 10.7 þ 0.6 46.9 þ 4.9
MBP-T43NTR-Gi (n = 4) 5 mM MgCl2 9.91 þ 0.09 8.95 þ 0.07 35.0 þ 2.5 34.6 þ 2.4
MBP-T43NTR-Gi/q (n = 4) 5 mM MgCl2 10.08 þ 0.05 8.82 þ 0.12 12.9 þ 1.5 49.0 þ 1.7
MBP-T43NTR-Gi/s (n = 4) 5 mM MgCl2 9.81 þ 0.12 8.89 þ 0.11 30.1 þ 1.1 28.2 þ 7.3
MPB (negative control) (n = 1) none ND ND ND ND
Ligand binding assays were performed in TEBB bu¡er. MgCl2 was added when indicated. Data are shown þ S.E.M. Bmax values are given for
the combined high- and low-a⁄nity states. The di¡erences between the mean pKDL values (low-a⁄nity state) are not statistically signi¢cant
(Anova: P = 0.37); similarly, the di¡erences between the pKDH values (high-a⁄nity state) are not statistically signi¢cant (Anova: P = 0.11) ex-
cept that marked by *. BH : average percentage of receptors in the high-a⁄nity state; negative control: crude membranes prepared from E. coli
DH5K containing the parental expression plasmid pRG/III-hs-MBP; ND: no speci¢c [3H]NT binding detected.
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terminus. Experiments conducted on E. coli membranes con-
taining MBP-T43NTR-Gi revealed a highly signi¢cant
(P6 0.001 as compared to basal nucleotide binding, t-test)
response to NT (Fig. 3A). Concentration^response curves
(Fig. 3B) gave an pEC50 value of 7.88 þ 0.25 which is identical
to the potency of NT measured in [35S]GTPQS assays using
CHO-NTR cell homogenates [26]. Experiments with MBP-
T43NTR-Gq did not reveal an increase in [35S]GTPQS binding
after the addition of NT using the assay conditions described
in Section 2.4. However, an indication for the functional cou-
pling of T43NTR with GKq came from [35S]GTPQS binding in
the presence of (NH4)2SO4 at a concentration of 0.5 M [30].
After addition of NT, a 24% increase in [35S]GTPQS speci¢c
binding to MBP-T43NTR-Gq was observed (one experiment
in quadruplicate, data not shown). To further show receptor
interaction with GKq-type proteins, T43NTR was fused to a
chimeric GKi1 subunit, in which the six C-terminal amino acid
residues were replaced with the equivalent sequences of the
GKq protein (MBP-T43NTR-Gi/q). This approach accounts
for the importance of the GK C-terminus for receptor specif-
icity, and bene¢ts from the high intrinsic guanine nucleotide
exchange activity of the GKi subunit. As shown in Fig. 3A,
highly signi¢cant NT-induced [35S]GTPQS binding was ob-
served with the MBP-T43NTR-Gi/q construct. The agonist-
induced increase in [35S]GTPQS speci¢c binding above basal
was signi¢cantly higher (P6 0.005, t-test) for the chimeric
-Gi/q fusion (269 þ 41%) compared to that for the wild-type
-Gi construct (77 þ 2.5%) (Fig. 3B). The pEC50 value of
7.95 þ 0.16 for NT-induced [35S]GTPQS binding was similar
to that obtained with MBP-T43NTR-Gi (Fig. 3B).
To demonstrate that coupling of T43NTR was speci¢c for
GKq and GKi1, but not the e¡ect of simple physical proximity
of the receptor and the GK subunit in the fusion constructs,
MBP-T43NTR-Gi/s, containing the chimeric GKi1 subunit
with the six C-terminal amino acid residues of GKs, was sub-
ject to [35S]GTPQS binding assays. Although no functional
response to NT was measured (Fig. 3A), a substantial basal
binding of [35S]GTPQS to MBP-T43NTR-Gi/s was detected
similar to that obtained with MBP-T43NTR-Gi and MBP-
T43NTR-Gi/q, indicating that the GKi=s subunit was able to
bind nucleotide under our experimental conditions.
The NT-induced [35S]GTPQS binding to MBP-T43NTR-Gi
and MBP-T43NTR-Gi/q was found to be completely inhib-
ited by the competitive antagonist SR48692 [31] (used at a
concentration of 1 WM) (Fig. 3C). Such inhibition was also
obtained with CHO-NTR membranes. Under our experimen-
tal conditions, the compound SR48692 did not reduce the
basal binding of [35S]GTPQS to E. coli model membranes or
to CHO-NTR membranes.
4. Discussion
We have analyzed the coupling of NTR to GK proteins by
agonist and GTPQS binding assays using GPCR^GK fusion
constructs expressed in E. coli. Our experimental results sug-
gest the interaction of NTR with GKq and GKi1, but not with
GKs.
There is good evidence that activation of NTR leads to
hydrolysis of inositol phospholipid [32^34] by activation of
phospholipase C through both PTX-sensitive [11] and PTX-
insensitive G-proteins [14,16], presumably belonging to the
Gi=o and Gq=11 families, respectively. Furthermore, both pos-
itive and negative modulation of adenylyl cyclase activity in
response to NT have been reported in mammalian cells ex-
pressing NTR [13,17]. To investigate the interaction of rat
NTR with G-proteins, we used a GPCR^GK fusion protein
approach [20,35^41] because initial reconstitution experiments
with partially puri¢ed GKqLQ (expressed in insect cells) and E.
coli membrane-inserted MBP-T43NTR-TrxA-H10 revealed
that the detergents used for the puri¢cation of GKqLQ by
immobilized metal a⁄nity chromatography [42] interfered
with NT binding to T43NTR (data not shown).
[3H]NT binding to MBP-T43NTR-Gq revealed a signi¢-
cantly higher proportion of receptors in the high-a⁄nity state
compared to that of MBP-T43NTR-TrxA-H10 (Table 1). This
may indicate the stabilization of the receptor high-a⁄nity
state by the interaction of T43NTR with GKq. The incomplete
conversion of MBP-T43NTR-Gq into its high-a⁄nity confor-
mation is likely due to inherent properties of this type of
fusion construct; similar results have been found and dis-
Fig. 1. Schematic representation of the MBP-T43NTR fusion pro-
teins analyzed in this study. The boxes shown are not drawn to
scale. The abbreviations for the modules of the receptor fusion pro-
teins are as follows. MBP, mature E. coli MBP; T43NTR, truncated
rat NTR; TrxA-H10, E. coli thioredoxin with a deca-histidine tail ;
Gq, mouse GKq protein; Gi, rat GKi1 subunit; Gi/q, GKi1 subunit
in which the six C-terminal amino acid residues were replaced with
the six C-terminal residues of GKq ; Gi/s, GKi1 subunit containing
the six C-terminal amino acid residues of GKs.
Fig. 2. Binding of [3H]NT to the membrane-inserted fusion protein
MBP-T43NTR-Gq. (A) Saturation binding at equilibrium. Washed
E. coli membranes were incubated for 30 min in TEBB bu¡er sup-
plemented with MgCl2, with increasing concentrations of radiola-
beled agonist. Separation of bound from free ligand was achieved
by centrifugation. The results shown are from a typical experiment
performed in duplicate. In many cases, the error bars are smaller
than the symbols. (B) Scatchard transformation of the data.
FEBS 24717 26-3-01
R. Grisshammer, E. Hermans/FEBS Letters 493 (2001) 101^105 103
cussed for L-adrenergic receptor GKs and A1 adenosine recep-
tor GKi fusion proteins [35,38,40,43]. To test functional cou-
pling of T43NTR with GKq, [35S]GTPQS binding experiments
were performed using MBP-T43NTR-Gq. Guanine nucleotide
exchange experiments have been found to be much more dif-
¢cult to perform for GKq due to lower intrinsic guanine nu-
cleotide exchange kinetics than for GKi proteins
[30,37,38,44,45]. However, we observed NT-induced nucleo-
tide exchange in the presence of (NH4)2SO4, which has been
reported to accelerate the dissociation of bound GDP from
GKq [30]. To further show that coupling of T43NTR was
speci¢c for GKq, T43NTR was fused to a chimeric GKi1 sub-
unit, in which the six C-terminal amino acid residues were
replaced with the equivalent sequences of the GKq protein
(MBP-T43NTR-Gi/q). This approach relies on the notion
that the extreme C-terminus of a GK subunit encodes much
(although not all) of its speci¢city for the interaction with a
receptor [46^49]. In addition, this approach bene¢ts from the
high intrinsic guanine nucleotide exchange activity of the GKi
subunit. Indeed, signi¢cant NT-induced [35S]GTPQS binding
was observed with the MBP-T43NTR-Gi/q construct (Fig.
3). Furthermore, [3H]NT saturation binding revealed a similar
proportion of the fusion being in the high-a⁄nity state as was
observed for MBP-T43NTR-Gq (Table 1). To show that the
coupling speci¢city to T43NTR was contributed by the GKq
C-terminus, but not the result of simple physical proximity of
receptor and the GKi=q subunit, the fusion construct MBP-
T43NTR-Gi/s, containing the chimeric GKi1 subunit with
the six C-terminal amino acid residues of GKs, was subject
to [35S]GTPQS and [3H]NT binding assays. No NT-induced
nucleotide exchange was observed (Fig. 3A), nor did the pres-
ence of the GKi=s moiety lead to an increase in the percentage
of receptors in the high-a⁄nity state compared to that of
MBP-T43NTR-TrxA-H10 (Table 1). Taken together, these
data suggest interaction of T43NTR with GKq.
Experimental evidence indicates that NTR couples to PTX-
sensitive G-proteins when expressed in CHO cells [21]. There-
fore, the fusion protein MBP-T43NTR-Gi was subject to
[3H]NT and [35S]GTPQS binding experiments to investigate a
possible interaction of T43NTR with the GKi1 subunit. Ago-
nist binding assays gave an average BH value of 34.6% (Table
1). This was lower than that obtained for MBP-T43NTR-Gq.
However, [35S]GTPQS experiments showed a robust response
after addition of NT (Fig. 3) supporting evidence for func-
tional coupling of T43NTR with GKi1.
Most of the e¡ects of NT in tissue and eukaryotic cell
models have been attributed to the activation of phospholi-
pase C suggesting the involvement of Gq=11-type proteins, but
fewer reports have noted the coupling of NTR to other G-
proteins (for review see [33]). Indeed, our data show the pref-
erential interaction of T43NTR with GKq compared to that
with GKi1. The percentage of receptors in the high-a⁄nity
state is higher for MBP-T43NTR-Gq and MBP-T43NTR-
Gi/q than that for MBP-T43NTR-Gi (Table 1). In addition,
the speci¢c NT-induced increase in [35S]GTPQS binding is up
to 9-fold higher for MBP-T43NTR-Gi/q compared to that of
Fig. 3. GTPQS binding to E. coli membranes containing MBP-
T43NTR fusion proteins. (A) NT-induced [35S]GTPQS binding to E.
coli membrane-inserted MBP-T43NTR-GK fusion proteins or to ho-
mogenates of transfected CHO-NTR cells expressing the rat NTR.
Data shown are average þ S.E.M. from 3^10 di¡erent experiments
performed at least in duplicate. The amplitudes of the responses
(percent increase in [35S]GTPQS binding above basal) measured at a
NT concentration of 1036 M are 23 þ 33% for MBP-T43NTR-Gq
(n = 3), 183 þ 34% for MBP-T43NTR-Gi (n = 10), 388 þ 52% for
MBP-T43NTR-Gi/q (n = 10), 59 þ 21% for MBP-T43NTR-Gi/s
(n = 4) and 170 þ 19% for CHO-NTR (n = 4). Statistical analysis by
t-test: #, ## and ###, basal binding is signi¢cantly di¡erent from
non-speci¢c binding with a P value 6 0.05, 6 0.01 and 6 0.001, re-
spectively; * and ***, NT-induced binding is signi¢cantly di¡erent
from basal binding with P values 6 0.05 and 6 0.001, respectively.
(B) Concentration^response curves for NT-induced [35S]GTPQS
binding to MBP-T43NTR-Gi (squares) or MBP-T43NTR-Gi/q (tri-
angles). Data shown are average þ S.E.M. from ¢ve (-Gi) and six
(-poGi/q) di¡erent experiments performed at least in duplicate.
pEC50 values of 7.88 þ 0.25 and 7.95 þ 0.16, and average values for
basal speci¢c binding of 11 675 þ 4357 cpm/mg protein and
7096 þ 653 cpm/mg protein were obtained for the -Gi and the -Gi/q
fusion proteins, respectively. The amplitudes of the maximal re-
sponses calculated from these experiments (percent increase in
[35S]GTPQS speci¢c binding above basal) are 77 þ 2.5% for MBP-
T43NTR-Gi and 269 þ 41% for MBP-T43NTR-Gi/q. (C) Inhibition
by SR48692 of NT-induced [35S]GTPQS binding to MBP-T43NTR-
Gi and -Gi/q fusion proteins or to homogenates of transfected
CHO-NTR cells. Data shown are average þ S.E.M. from three dif-
ferent experiments performed in quadruplicate.
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MBP-T43NTR-Gi when calculated in molar terms of the re-
ceptor fusion proteins, given their di¡erent expression levels
determined by agonist binding (Table 1, Fig. 3B). These re-
sults may re£ect the predominant functional coupling with
Gq=11-type proteins as was found in CHO-NTR cells [21].
In this report we have addressed the selectivity of the inter-
action of NTR with GK protein subunits. We ¢nd that bacte-
rially expressed MBP-T43NTR fusion proteins show function-
al coupling to GKq and GKi1 subunits linked to the receptor
C-terminus. The results support our previous ¢ndings of the
dual coupling of NTR to PTX-sensitive and -insensitive G-
proteins in CHO cells with preference for Gq=11-type proteins.
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